United States · FDA National Drug Code directory
Sumatriptan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85766-095_5031bc93-6ea4-e9d4-e063-6394a90a5afd
- Product NDC
- 85766-095
- Form
- TABLET
- Composition / generic term
- Sumatriptan Succinate
- Labeler
- Sportpharm LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090817
- Source listing expiry
- 20271231
Source-listed ingredients
- SUMATRIPTAN SUCCINATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (85766-095-09) / 9 TABLET in 1 BLISTER PACK · 85766-095-09
- 36 TABLET in 1 BOTTLE (85766-095-10) · 85766-095-10
- 20 TABLET in 1 BOTTLE (85766-095-20) · 85766-095-20
- 30 TABLET in 1 BOTTLE (85766-095-30) · 85766-095-30
- 36 TABLET in 1 BOTTLE (85766-095-36) · 85766-095-36
- 60 TABLET in 1 BOTTLE (85766-095-60) · 85766-095-60
- 90 TABLET in 1 BOTTLE (85766-095-90) · 85766-095-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →